Kenneth Jin Chang Lim, MBBS, discusses the failure of dexamethasone to reduce rates of neurotoxicity in myeloma with high ALC after CAR T-cell therapy.
Kenneth Jin Chang Lim, MBBS
Advertisement
Kenneth Jin Chang Lim, MBBS, is a hematology fellow at St Vincent’s Hospital Melbourne in Australia.
Articles by Kenneth Jin Chang Lim, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
2
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Is Associated With Neurotoxicity, NRM in Myeloma
4
TRX103 Tr1 Cell Therapy Shows Manageable Safety and Dose-Dependent Kinetics After HLA-Mismatched HCT in Hematologic Malignancies
5